The global minimally invasive surgery devices market size was estimated to be USD 29.34 billion in 2023 and is expected to reach at USD 91.7 billion by 2033 with a CAGR of 10.92% during the forecast period 2023-2033. Growing prevalence of lifestyle-related & chronic disorders, increasing preference for minimally invasive procedures, surge in number of surgeries performed, rising technological advancements, growing adoption of advanced robotics in ambulatory surgical centres, increasing demand for cosmetic surgeries, and surge in launch of technologically advanced products by major market players are some of the key factors boosting the market growth.
Surge in launch of technologically advanced products by major market players is predicted to boost the market growth during the forecast period. For instance, in April 2021, In partnership with Veran Medical Technologies Inc., Olympus Corporation introduced the US bronchoscopy lineup of H-SteriScope Single-Use Bronchoscopes, a collection of five high-quality endoscopes designed for advanced diagnostic and therapeutic procedures, all cleared under 510(k) regulations.
By Device, Handheld Instruments was the highest revenue-grossing segment in the global minimally invasive surgery devices market in 2022 owing to increasing prevalence of chronic diseases, growing technological advancements, and increasing launch of new devices. Additionally, electrosurgical devices is predicted to grow at fastest CAGR during forecast period owing to the rising incidences of chronic disorders, growing ageing population, surge in number of minimally invasive surgical processes, increasing demand for cosmetic operations, and rise in introduction of advanced products. For instance, in September 2022, Olympus Corporation unveiled the THUNDERBEAT™ Open Fine Jaw Type X surgical energy devices, designed for both minimally invasive and open surgery applications.
By Application, Cardiothoracic Surgery was the highest revenue-grossing segment in the global minimally invasive surgery devices market in 2022 owing to the increasing prevalence of cardiac disorders, growing adoption of new technologies to perform cardiovascular surgeries, and rising launch of new products by market players. Additionally, Orthopaedic surgery is predicted to grow at fastest CAGR during the forecast period owing to the surge in number of patients with orthopaedic disorders, growing geriatric population, rising technological advancements, and increasing launch of innovative products. For instance, in June 2023, IMPLANET revealed the introduction of the MIS range, a system for minimally invasive pedicle screw positioning, developed in collaboration with their partner Sanyou Medical.
By End-user, Hospitals & Specialty Clinics was the highest revenue-grossing segment in the global minimally invasive surgery devices market in 2022 owing to the increasing minimally invasive surgical procedures performed in hospitals & clinics, presence of highly skilled professionals, rising demand of technologically advanced minimally invasive surgical instruments, and growing introduction of advanced products. For instance, in June 2022, Ethicon, a division of Johnson & Johnson MedTech, has introduced the ECHELON 3000 Stapler in the United States. This digitally enabled device offers surgeons effortless one-handed powered articulation, catering to the specific requirements of their patients. Additionally, Ambulatory Surgery Centres is predicted to grow at fastest CAGR during the forecast period owing to the growing adoption of advanced robotics in ambulatory surgical centres and rising technological advancements.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising burden of chronic diseases, surge in awareness about minimally invasive surgical procedures, growing number of surgeries performed within the region, rising technological advancements in various surgical devices, and surge in product approvals by regulatory bodies. For instance, in March 2021, Misonix Inc. has obtained a Health Canada license for the neXus Ultrasonic Surgical System. The neXus system is a robust, well-integrated, and user-friendly platform that utilizes cutting-edge ultrasonic technology to enhance efficiency and effectiveness in a wide range of surgeries, including laparoscopic procedures. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing prevalence of chronic diseases, rising medical tourism, growing favourable government policies, surge in number of patients undergoing surgical treatments, and increase in launch of innovative systems by market players. For instance, In December 2022, Abbott has introduced NavitorTM, its newest transcatheter aortic valve implantation (TAVI) system, enabling the minimally invasive device's accessibility to individuals in India.
Surge in launch of technologically advanced products by major market players is predicted to boost the market growth during the forecast period. For instance, in April 2021, In partnership with Veran Medical Technologies Inc., Olympus Corporation introduced the US bronchoscopy lineup of H-SteriScope Single-Use Bronchoscopes, a collection of five high-quality endoscopes designed for advanced diagnostic and therapeutic procedures, all cleared under 510(k) regulations.
By Device, Handheld Instruments was the highest revenue-grossing segment in the global minimally invasive surgery devices market in 2022 owing to increasing prevalence of chronic diseases, growing technological advancements, and increasing launch of new devices. Additionally, electrosurgical devices is predicted to grow at fastest CAGR during forecast period owing to the rising incidences of chronic disorders, growing ageing population, surge in number of minimally invasive surgical processes, increasing demand for cosmetic operations, and rise in introduction of advanced products. For instance, in September 2022, Olympus Corporation unveiled the THUNDERBEAT™ Open Fine Jaw Type X surgical energy devices, designed for both minimally invasive and open surgery applications.
By Application, Cardiothoracic Surgery was the highest revenue-grossing segment in the global minimally invasive surgery devices market in 2022 owing to the increasing prevalence of cardiac disorders, growing adoption of new technologies to perform cardiovascular surgeries, and rising launch of new products by market players. Additionally, Orthopaedic surgery is predicted to grow at fastest CAGR during the forecast period owing to the surge in number of patients with orthopaedic disorders, growing geriatric population, rising technological advancements, and increasing launch of innovative products. For instance, in June 2023, IMPLANET revealed the introduction of the MIS range, a system for minimally invasive pedicle screw positioning, developed in collaboration with their partner Sanyou Medical.
By End-user, Hospitals & Specialty Clinics was the highest revenue-grossing segment in the global minimally invasive surgery devices market in 2022 owing to the increasing minimally invasive surgical procedures performed in hospitals & clinics, presence of highly skilled professionals, rising demand of technologically advanced minimally invasive surgical instruments, and growing introduction of advanced products. For instance, in June 2022, Ethicon, a division of Johnson & Johnson MedTech, has introduced the ECHELON 3000 Stapler in the United States. This digitally enabled device offers surgeons effortless one-handed powered articulation, catering to the specific requirements of their patients. Additionally, Ambulatory Surgery Centres is predicted to grow at fastest CAGR during the forecast period owing to the growing adoption of advanced robotics in ambulatory surgical centres and rising technological advancements.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising burden of chronic diseases, surge in awareness about minimally invasive surgical procedures, growing number of surgeries performed within the region, rising technological advancements in various surgical devices, and surge in product approvals by regulatory bodies. For instance, in March 2021, Misonix Inc. has obtained a Health Canada license for the neXus Ultrasonic Surgical System. The neXus system is a robust, well-integrated, and user-friendly platform that utilizes cutting-edge ultrasonic technology to enhance efficiency and effectiveness in a wide range of surgeries, including laparoscopic procedures. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing prevalence of chronic diseases, rising medical tourism, growing favourable government policies, surge in number of patients undergoing surgical treatments, and increase in launch of innovative systems by market players. For instance, In December 2022, Abbott has introduced NavitorTM, its newest transcatheter aortic valve implantation (TAVI) system, enabling the minimally invasive device's accessibility to individuals in India.
Segmentation: Minimally Invasive Surgery Devices Market Report 2022 - 2033
Minimally Invasive Surgery Devices Market Analysis & Forecast by Device 2022 - 2033 (Revenue USD Bn)
- Electrosurgical Devices
- Handheld Instruments
- Guiding Devices
- Inflation Devices
- Auxiliary Devices
- Cutter Instruments
- Monitoring & Visualization Devices
Minimally Invasive Surgery Devices Market Analysis & Forecast by Application 2022 - 2033 (Revenue USD Bn)
- Gastrointestinal Surgery
- Cardiothoracic Surgery
- Orthopaedic Surgery
- Gynaecological Surgery
- Cosmetic & Bariatric Surgery
- Urology Surgery
- Others
Minimally Invasive Surgery Devices Market Analysis & Forecast by End-user 2022 - 2033 (Revenue USD Bn)
- Ambulatory Surgery Centres
- Hospitals & Specialty Clinics
Minimally Invasive Surgery Devices Market Analysis & Forecast by Region 2022 - 2033 (Revenue USD Bn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Minimally Invasive Surgery Devices Market: Device Estimates & Trend Analysis
8. Minimally Invasive Surgery Devices Market: Application Estimates & Trend Analysis
9. Minimally Invasive Surgery Devices Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Minimally Invasive Surgery Devices Market
12. Europe Global Minimally Invasive Surgery Devices Market
13. Asia Pacific Global Minimally Invasive Surgery Devices Market
14. Latin America Global Minimally Invasive Surgery Devices Market
15. MEA Global Minimally Invasive Surgery Devices Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Olympus Corporation
- HOYA Corporation
- Abbott Laboratories
- Koninklijke Philips NV
- Boston Scientific
- Medtronic PLC
- Stryker
- Intuitive Surgical Inc.
- Healthineer AG
- Ethicon Inc. (Johnson & Johnson)
- Depuy Synthes
- Zimmer Biomet
- GE Healthcare
- Siemens
- Nuvasive Inc.
- Intutive Surgical Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | August 2023 |
| Forecast Period | 2022 - 2033 |
| Estimated Market Value ( USD | $ 29.34 Billion |
| Forecasted Market Value ( USD | $ 91.7 Billion |
| Compound Annual Growth Rate | 10.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
